One of the current issues on everyone’s mind today is the quality and authentication of prescription drugs. With the rising cost of prescriptions, individuals are ordering online, senators are proposing drug importation, and manufacturers are outsourcing their raw materials. All of this has compromised our drug supply.
Counterfeits have plagued the medical community for longer than most people realize. Did you know that the first regulatory action against counterfeit medicines in the U.S. was the Pure Food and Drugs Act of 1906?
It was titled “An Act of preventing the manufacture, sale or transportation of adulterated or misbranded or poisonous or deleterious foods, drugs, medicines, and liquors, and for relating traffic therein, and for other purposes.”
Since then, great strides have been made both by those developing new drugs to save us and by those profiteering pirates who contrive to make copies good enough to visually fool even the most learned man. But now science is causing a glitch in the illicit trade program. A new “scientist-in-a-box” technology which can look at a drug’s molecular level right on the front line has been unveiled!
Think of what this means: bringing real-time analysis to manufacturers, wholesalers, and repackagers. Forewarned is forearmed - and the sooner you can detect a counterfeiter the soon you can put your company and the public out of harm’s way!
Monday, March 10, 2008
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment